BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2001
View Archived Issues
Licensing opportunity from NIH: biologically active FLAG epitope-tagged TGF-beta protein
Read More
Novel inhibitors of retrovirus replication available for licensing from NIH
Read More
Revised safety information for Sporanox labeling in Canada
Read More
Mechanism of action of HIV-inactivating protein cyanovirin N explored
Read More
Oritavancin rapidly kills multidrug-resistant S. pneumoniae in vitro
Read More
Safety and efficacy of dopamine agonists in treatment of restless legs syndrome
Read More
Results from studies on neuropathic pain treatments presented at AAN meeting
Read More
Rabbit studies indicate safety, efficacy of KUR-1246 in threatened premature delivery
Read More
Neurocrine Biosciences advances NBI-34060 towards phase III trials for insomnia
Read More
Successful completion of initial human trial for testosterone patch announced by 3M
Read More
Second azelaic acid-based acne product cleared for launch by FDA
Read More
UR-3216 emerges as a promising new gpIIb/IIIa antagonist for cardiovascular disorders
Read More
Oral therapy for CML developed at Novartis approved by FDA
Read More
Activation of PPARgamma associated with apoptosis in gliomas
Read More
Proteasome inhibitor PS-519 holds promise as a therapy for psoriasis
Read More
FDA approves Almirall Prodesfarma's 5-HT1B/1D agonist for treatment of migraine
Read More
Low-dose loratadine has steroid-sparing effect in Crohn's disease patients
Read More
Johnson & Johnson acquisition of Alza proceeds on schedule
Read More
KS Biomedix moves KSB-302 into phase IIb for RA
Read More
Antifungal agent produced by species of Phoma patented by Sankyo
Read More
TPO mimetics in development at GSK
Read More
Shionogi presents new series of HIV integrase inhibitors
Read More
Merger of BioChem Pharma and Shire officially closes
Read More
Inhibitors of VSMC proliferation derived from PGE reported by Taisho
Read More
Pfizer presents new glycogen phosphorylase inhibitors and potential uses
Read More
6-Azauracils from Pfizer useful as thyroid receptor ligands
Read More